DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Ascierto PA, McArthur GA, Dréno B. et al.
Cobimetinib combined with vemurafenib in advanced BRAF V600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial.
Lancet Oncol 2016;
17: 1248-1260
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.